Today's Read...

Frutarom Signs Agreement for Exclusive Global License to Produce and Market a Unique Plant Extract to Reduce and Stabilize Glucose Levels in Blood of Diabetes and Pre-Diabetes Patients



HAIFA, Israel, September 20, PRNewswire) Frutarom has signed an exclusive global licensing agreement with D-Herb, of the NGT technological incubator in Nazareth, Israel, to produce and globally market a unique herbal extract, for the reduction and stabilization of glucose levels in the blood of diabetes and pre-diabetes patients. Frutarom intends to market and sell this unique extract, whose activity is supported by clinical trials that yielded excellent results, to the nutraceuticals, pharmaceuticals, functional food and health food industries, as part of its unique natural product portfolio.

Type II Diabetes has reached epidemic proportions and will continue to escalate due to a rise in obesity and an ageing population.

The number of diabetics in the world is estimated at 190 million, of which 20 million are in the USA. Forty percent (40%) of American diabetics use nutraceutical products in addition to conventional drug treatment. The American Diabetes Association estimates that an additional 41 million Americans suffer from pre-diabetes and recommends the use of nutraceuticals and food additives to reduce glucose levels in order to help prevent or postpone the onset of the disease. The US market for anti- diabetes natural products is estimated at US$ 50 million and last year grew 30%. This unique extract is the only clinically proven, natural product that reduces HbA1c levels in diabetes Type 2 patients (the most reliable test when measuring diabetes).

Read more of this article here...

For more information, visit www.frutarom.com.